Less Can Be More - A Finite Treatment Approach for HBeAg-negative Chronic Hepatitis B

Hepatology - United States
doi 10.1002/hep.29821
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

IL28B Polymorphism Correlates With Active Hepatitis in Patients With HBeAg-Negative Chronic Hepatitis B

PLoS ONE
Multidisciplinary
2013English

Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso

Open Journal of Gastroenterology
2016English

Contemporary Blepharoplasty: Less Can Be More

Expert Review of Dermatology
2010English

Positive Association Between Serum Apolipoprotein M Levels and Hepatitis B Virus DNA Load in HBeAg-negative Chronic Hepatitis B

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2016English

The Clinical Significance of Quantitative HBSAG in Patients With HBEAG Negative Chronic Hepatitis B

Acta Medica Saliniana
Medicine
2019English

Significance of Definitions of Relapse After Discontinuation of Oral Antivirals in HBeAg-negative Chronic Hepatitis B

Hepatology
MedicineHepatology
2018English

HBV DNA Suppression and HBsAg Clearance in HBeAg Negative Chronic Hepatitis B Patients on Lamivudine Therapy for Over 5years

Journal of Hepatology
Hepatology
2012English

Bushenjianpi Formula Combined With Entecavir for HBeAg-negative Chronic Hepatitis B Patients: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet
Medicine
2016English

Characteristics of Chronic Hepatitis B: Lower Alanine Transaminase Level to Start Treatment in HBEAG Negatives

Gut
Gastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy